Reviewing Tenet Healthcare (THC) and Chemed (CHE)

Chemed (NYSE: CHE) and Tenet Healthcare (NYSE:THC) are both healthcare facilities & services – nec companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership.

Earnings and Valuation

This table compares Chemed and Tenet Healthcare’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Chemed $1.58 billion 2.70 $108.74 million $4.49 59.34
Tenet Healthcare $19.62 billion 0.09 -$192.00 million ($5.50) -3.13

Chemed has higher earnings, but lower revenue than Tenet Healthcare. Tenet Healthcare is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Chemed and Tenet Healthcare, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemed 0 2 1 0 2.33
Tenet Healthcare 2 6 6 0 2.29

Chemed presently has a consensus target price of $228.50, suggesting a potential downside of 14.24%. Tenet Healthcare has a consensus target price of $18.31, suggesting a potential upside of 6.19%. Given Tenet Healthcare’s higher possible upside, analysts clearly believe Tenet Healthcare is more favorable than Chemed.

Volatility and Risk

Chemed has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500. Comparatively, Tenet Healthcare has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500.


Chemed pays an annual dividend of $1.12 per share and has a dividend yield of 0.4%. Tenet Healthcare does not pay a dividend. Chemed pays out 24.9% of its earnings in the form of a dividend. Chemed has raised its dividend for 9 consecutive years.


This table compares Chemed and Tenet Healthcare’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Chemed 4.62% 27.69% 15.16%
Tenet Healthcare -2.85% -5.61% -0.23%

Insider & Institutional Ownership

97.7% of Chemed shares are owned by institutional investors. 4.9% of Chemed shares are owned by company insiders. Comparatively, 3.1% of Tenet Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.


Chemed beats Tenet Healthcare on 12 of the 17 factors compared between the two stocks.

About Chemed

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

About Tenet Healthcare

Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital. The Company’s Ambulatory Care segment includes the operations of its USPI joint venture and its Aspen facilities. As of December 31, 2016, Conifer provided one or more of the business process services described above from 20 service centers to more than 800 Tenet and non-Tenet hospital and other clients in over 40 states. As of December 31, 2016, the Company operated 20 short-stay surgical hospitals, over 470 outpatient centers, and nine facilities in the United Kingdom.

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with's FREE daily email newsletter.

Leave a Reply